Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Intestinal Neuroendocrine Tumor"'
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Background: Small intestinal neuroendocrine tumors (SI-NETs) are the most common malignant tumors of the small intestine, with many patients presenting with metastases and their incidence increasing. We aimed to find effective diagnostic biomarkers f
Externí odkaz:
https://doaj.org/article/36b72ef5cd3c4e0da4f8a71e2e76138e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guillermo Hernández-Hernández, Ana Soto Sánchez, Manuel Ángel Barrera-Gómez, Irene Ferrer Vilela, José Gregorio Díaz Mejías, María De Armas-Conde, Luis Eduardo Pérez-Sánchez, Moisés Hernández Barroso
Publikováno v:
Revista Colombiana de Cancerología. 25:222-225
La localización extranodal gastrointestinal del linfoma de Hodgkin comprende el 5% de todos los linfomas. Dentro de este grupo, el linfoma anal primario representa menos del 0,05%, siendo por tanto una entidad extremadamente rara. Por otro lado, los
Publikováno v:
Gastroenterologìa, Vol 55, Iss 3, Pp 206-210 (2021)
GASTROENTEROLOGY; Vol. 55 No. 3 (2021); 206-210
Гастроэнтерология-Gastroenterologìa; Том 55 № 3 (2021); 206-210
Гастроентерологія-Gastroenterologìa; Том 55 № 3 (2021); 206-210
GASTROENTEROLOGY; Vol. 55 No. 3 (2021); 206-210
Гастроэнтерология-Gastroenterologìa; Том 55 № 3 (2021); 206-210
Гастроентерологія-Gastroenterologìa; Том 55 № 3 (2021); 206-210
Background. Every year, the number of people with rare forms of the disease is increasing worldwide. One of these is the catastrophic antiphospholipid syndrome — Asherson’s syndrome. To date, it is being actively studied, but the pathophysiologic
Autor:
R Vera García, A Irigaray Echarri, E Muruzábal Huarte, J De Carlos Artajo, E. Anda Apiñániz, N Castro Unanua, J.M. Zubiria Gortazar
Publikováno v:
Anales del Sistema Sanitario de Navarra. 43:103-106
Everolimus is an mTOR inhibitor, approved as a treatment for cancer and as an immunosuppressant agent in solid organ transplantation; it frequently produces toxic metabolic effects, particularly of the most severe kind. Its use can cause hyperglycemi
Publikováno v:
Precision Clinical Medicine. 3:147-152
A 57-year-old male presenting with spontaneously relieved abdominal cramp and distension was admitted to the West China Hospital. The diagnosis remained unclear after colonoscopy and computed tomography. Double contrast-enhanced ultrasonography was t
Autor:
Riccardo Faccini, Giuseppe Quero, Teresa Scotognella, Francesco Collamati, M. Fischetti, Micol De Simoni, Ilaria Fratoddi, Alessandro Giordano, Sergio Alfieri, Silvio Morganti, V. Bocci, R. Mirabelli, Elena Solfaroli Camillocci, Iole Venditti, Angela Collarino, Giacomo Traini, Antonella Cartoni, Daria Maccora, Carlo Mancini-Terracciano, Dante Rotili
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
The possibility to use β− decaying isotopes for radioguided surgery (RGS) has been recently proposed, and first promising tests on ex-vivo samples of Meningioma and intestinal Neuroendocrine Tumor (NET) have been published. This paper reports a st
Autor:
Nynne Emilie Hummelshøj, Gerda Elisabeth Villadsen, Gitte Dam, Lars Pedersen, Astrid Hjelholt
Publikováno v:
Hummelshøj, N E, Dam, G, Pedersen, L H, Hjelholt, A & Villadsen, G E 2021, ' First-generation somatostatin ligand receptor treatment in a pregnant patient with a neuroendocrine tumor with liver metastases ', Endocrinology, Diabetes & Metabolism Case Reports, vol. 2021 . https://doi.org/10.1530/EDM-21-0126
Endocrinology, Diabetes & Metabolism Case Reports
Hummelshøj, N E, Dam, G, Pedersen, L H, Hjelholt, A & Villadsen, G E 2021, ' First-generation somatostatin ligand receptor treatment in a pregnant patient with a neuroendocrine tumor with liver metastases ', Endocrinology, Diabetes and Metabolism Case Reports, vol. 2021, no. 1, 21-0126 . https://doi.org/10.1530/EDM-21-0126
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2021)
Endocrinology, Diabetes & Metabolism Case Reports
Hummelshøj, N E, Dam, G, Pedersen, L H, Hjelholt, A & Villadsen, G E 2021, ' First-generation somatostatin ligand receptor treatment in a pregnant patient with a neuroendocrine tumor with liver metastases ', Endocrinology, Diabetes and Metabolism Case Reports, vol. 2021, no. 1, 21-0126 . https://doi.org/10.1530/EDM-21-0126
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2021)
Summary This rare case describes the course of a pregnancy in a patient with a disseminated small intestinal neuroendocrine tumor. The patient received treatment with first-generation somatostatin ligand receptor (SLR) every 4 weeks and had stable di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a13e25370affcb02efc299073e6b9c
https://pure.au.dk/portal/da/publications/firstgeneration-somatostatin-ligand-receptor-treatment-in-a-pregnant-patient-with-a-neuroendocrine-tumor-with-liver-metastases(b31cc580-8497-4fd7-8b7a-f6dd7fd441e1).html
https://pure.au.dk/portal/da/publications/firstgeneration-somatostatin-ligand-receptor-treatment-in-a-pregnant-patient-with-a-neuroendocrine-tumor-with-liver-metastases(b31cc580-8497-4fd7-8b7a-f6dd7fd441e1).html